Australia's 4DMedical hits more than 4-year high on FDA clearance for CT:VQ scans

4DMedical

05/09/2025 05:46

** 4DMedical 4DX.AX soars as much as 34.4% to A$1.76, highest since April 12, 2021; rises for third straight session

** U.S. FDA cleared CT:VQ - lung-imaging tech for monitoring ventilation–perfusion, co said on Thursday after-market

** Stock has been rising for past two sessions after co said its CT:VQ scans eligible for U.S. Medicare reimbursements

** Around 22.4 mln shares traded, 4.1x the 30-day avg

** 4DX last up 17.9%; more than triples YTD

 (Reporting by Shruti Agarwal in Bengaluru)

 ((Shruti.Agarwal@thomsonreuters.com))